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We assessed the reprducibilityofX-rayflu-
orescence-based lead measurements from
multiple me emeits made on a low-con-
cen on per ofpris phainitom and in
five sects measured five times oni two
occasions. Overa6-monthperiod, 220 mea-
surements of the same phantom were
obine andshowedastandrdeviationof
1.29 pg Pb (g plaster of paY)'. The two
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months apart and revealed a mean standard
deviation of 3.4 pg Pb (g bone mineral)'
and 5.1 pg Pb g bone mineralY7 fior male
and:femals, respectively. Our measured
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no sigifint di s been le As a
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ty we report here mean that X-ray fluores-
cence-based determinations ofbone lead
concentrations are reliable both over the
short and long term. Thus, reasnbl sized
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edchanges in c t andshould per-
mit acquisiion o lo dinal datawithin a
reasonable length of taie. Ki d: bone
lead, reprucibility, X-ray fluorescence..
Environ Health Perspect 102:690-694
(1994)
Measurements ofskeletal lead content by in
vivo X-ray fluorescence have yielded cross-
sectional data from which several important
conclusions have been drawn about bone
lead burdens in humans. First, several cross-
sectional surveys of nonoccupationally
exposed populations have shown that in vivo
tibia lead measurements represent an indexof
cumulative exposure to environmental (1,2)
and industrial (3,4) lead levels. Second,
when used as an index of cumulative expo-
sure, in vivo bone lead measurements have
proven valuable in discriminating between
occupationally and nonoccupationally
exposed persons (5). Third, and most impor-
tantly, it has been established that a strong
relationship exists between elevated blood
lead and bone lead in retired lead workers,
highlighting the importance of an endoge-
nous lead exposure (6,7).
With the knowledge that the body's
lead stores can be mobilized back into the
circulatory system, research questions are
now addressing the subclinical toxicity of
lead (8) released from bone. The release of
this endogenous lead store may be a direct
result of changes in bone mineral status
such as that experienced by women with
the onset ofmenopause (9). The outcomes
of such studies will depend strongly on
determining changes in bone lead over a
reasonable length of time. It is therefore
important that in vivo bone lead measure-
ments be reproducible.
Because published data on the repro-
ducibility of bone lead measurements are
limited (10-12), we set out to define the
short- and long-term reproducibility of
bone lead concentrations determined by
our measurement system both in phan-
toms and in human subjects. We also pre-
sent preliminary data that examine the dif-
ferences in tibia lead between the right and
left legs within individuals.
Materials and Methods
We determined the lead concentration in
phantoms and in subjects with an improved
09Cd K X-ray fluorescence system. Details
ofthe instrumentation ofthis upgraded sys-
tem have been described previously (1).
A bare cylindrical plaster ofparis phan-
tom with a nominal concentration of23 pg
Pb (g plaster of paris)Y was selected to
define in vitroreproducibility. The phantom
was measured over a 6-month period, dur-
ingwhich 220 measurements were recorded.
Each measurement lasted 1800 sec (clock
time), and care was taken to reproduce the
position of the phantom to eliminate the
effects of any concentration inhomogeneity
along or around the phantom.
Five subjects (three male, two female)
participated in the reproducibility trials.
They were selected on the basis that their
leg sizes represented a wide range of mea-
surement geometries. We assessed leg size
by the circumference at the midpoint
between the medial malleolus and the
tuberosity of the tibia. Two sets of five
measurements were performed at the mid-
point ofthe anteromedial aspect ofthe left
tibia ofeach subject. For each individual a
set of measurements was acquired mostly
within a 5-day period. We made the first
set of measurements in September 1992
and the second series in July 1993. Before
the second set of measurements were
repeated, however, two changes occurred
in our measurement system. First, the
detector resolution, as assessed by the full
width at half maximum of the coherent
peak, increased from 650 eV to 700 eV.
Second, we purchased a second 109Cd
source (1.1 GBq). In all five subjects the
first series of measurements were per-
formed with the older 109Cd source (0.50
GBq). In two of the three male subjects,
the second set ofmeasurements were done
with the new source. For the remaining
one male and two female subjects, the sec-
ond series of measurement were repeated
with the original source which was
reduced in activity (0.30 GBq) due to
decay over the 10 months separating the
two measurements. Consequently, we were
able to examine short-term reproducibility
at three different source strengths.
In 14 subjects (7 male, 7 female,) we
made a single measurement on each ofthe
left and right tibia. Again, the midpoint of
the anteromedial aspect of each tibia was
used, and measurement times ranged
between 1800 and 2000 sec.
Peak information from all spectra were
extracted using a nonlinear least-squares fit
based on the Marquardt algorithm (13).
We used chi-square analysis to assess the
variance associated with the serial phan-
tom measurements. We define measure-
ment reproducibility as the standard devia-
tion associated with the mean ofa series of
concentration measurements. The
Student's t-test was used to determine the
statistical significance of differences
between mean concentrations derived
from repeat measurements performed in
the in vivo part ofthe study. The t-distrib-
ution was also used to derive confidence
intervals associated with a measured
change in bone lead concentration.
Results
Figure 1 shows the results of measuring
the plaster of paris phantom over a 6-
month period. The mean concentration is
23.32 pg Pb (g plaster ofparis), with an
associated standard deviation of 1.29 pg
Pb (g plaster ofparis). Twice this devia-
tion is also indicated with the data set. As
expected for 220 measurements, 11 (5%)
lie outside the 2ay range. The calculated
uncertainty on a single measurement of
this phantom is approximately 1 pg Pb (g
plaster ofparis)Y . Therefore, there is a
30% difference between the predicted and
measured uncertainties. To examine this
difference, the ratio ofobserved to expect-
ed variance was evaluated using the
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reduced chi-square. If the observed vari-
ance were equal to the predicted variance,
then the reduced chi-square would be
equal to 1. For 219 degrees offreedom, the
reduced chi-square equals 1.66 and has an
associated p-value <0.02, indicating a sig-
nificant increase in variance associated with
making repeated measurements over a 6-
month period.
The results ofthe in vivo reproducibility
trial are summarized in Table 1. The means
and standard deviations of the two sets of
measurements are given, along with the
average calculated uncertainty associated
with a single measurement. As indicated,
among the five subjects the mean concen-
tration was significantly different in one
(p=0.03). The reproducibility in males
ranged from 2.1 to 5.3 pg Pb (g bone min-
eral ' and 2.4 to 9.1 pg Pb (g bone miner-
al) in females. Reproducibility could not
be related to source activity or leg size.
The six estimates of reproducibility in
males and four estimates in females can be
averaged to obtain typical values because
we selected our subjects to be representa-
tive of a wide range of in vivo variations.
These average results are 3.4 pg Pb (g bone
mineral)-' for males and 5.1 pg Pb (g bone
mineral)-I in females. With these estimates
ofvariability in typical subjects, confidence
intervals associated with a difference in two
sets of bone lead concentration measure-
ments can be derived from:
t[2(n -1),1-0.5a]i2ai cI=
A~n
where t[2(n-1),1-0.5a) is the 100(1-0.5a)
percentage point of a t-distribution with 2
(n-i) degrees offreedom, a is the estimated
Table 1. Mean and standard deviation ofthe two sets of in vivo measurements
pg Pb (g bone)-'
Subject(sex) Visit 1 Visit2 Leg circumference (cm)
1 (m) 7.28 ± 531* 12.70 ± 2.67b,* 46.0
(3.30)a (3.54)
2(m) 4.05 ± 2.07 1.97 ± 3.64 35.0
(2.41) (2.78)
3 (i) 6.43 ± 4.08 8.73 ± 2.40 37.0
(3.15) (3.95)
4(f) 5.82± 9.11 3.36 ±4.44 31.0
(5.10) (5.51)
5 (f) 4.69 ± 4.30 5.51 ± 2.40 27.5
(2.82) (3.20)
aAverage calculated uncertainty in parentheses.
b Measured with new source.
*Statistically significant (p <0.05).
Table2. Confidence intervals onthe difference between two sets of bone lead measurements
pg Pb (g bonemineral)-'
Level of confidence Number of measurements Male Female
95% 2 ± 14.6 ± 21.9
3 ±7.7 ±11.5
4 ±5.9 ±8.8
90% 2 ± 9.9 ± 14.8
3 ±5.9 ±8.8
4 ±4.7 ±7.0
80% 2 ±6.4 ± 9.6
3 ±4.2 ±6.3
4 ±3.5 ± 5.2
measurement reproducibility, and n is the
number of measurements in each of the
two measurement sets (14). Based on this
formula, the 80, 90 and 95% confidence
interval for both males and females were
calculated and are given in Table 2.
Differences in lead concentration
between the left and right tibia are
addressed in Table 3. The difference in
lead concentration is presented as a mean
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Figure 1. The results of 220 measurements of a low-concentration phantom. The mean concentration is
23.10 pg Pb (g plaster ofparisY with an associated SD of 1.29 pg Pb (g plaster ofparisV1. The calculated
uncertainty associated with a single measurement (o) is ±1 pg Pb (g plaster ofparis)V1.
Table 3. Mean and standard deviation ofthe dif-
ference between left and righttibia concentra-
tions
Male Female
Sample size 7 7
Mean Z 0.474 -0.069
SD 0.631 1.189
of individual Z scores calculated from the
following equation:
[R]-[L]
(cr +(TR
where [L] and [] are the measured con-
centrations, and 0L and 0R are the associ-
ated uncertainties. If there is no difference
between the lead concentration in each
tibia, then it is expected that the individual
Zvalues will be distributed with a mean of
0 and an SD of 1. For both sexes the dif-
ferences in concentration between legs
were not significant. Left and right concen-
trations were more strongly correlated in
males than females. However, a larger stan-
dard deviation (1.19) in the mean differ-
ence was recorded in our female group.
Discussion
Multiple measurements performed on the
plaster of paris phantom indicate that in
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vitro concentrations are highly repro-
ducible over the short and long term. We
previously reported the short term repro-
ducibility for this low-concentration phan-
tom as being 1.20 pg Pb(g plaster ofparis)-Y
(15). This estimate was derived from a set
of 29 consecutive measurements acquired
without repositioning. By extending these
phantom measurements over a longer term,
we have produced an estimate of repro-
ducibility that is less than 10% higher.
This suggests that factors such as small
changes in source activity, detector and
electronics performance, analytical proce-
dure, and repositioning errors do not greatly
contribute to the observed variance associ-
ated with an estimation oflead concentra-
tion in vitro.
The uncertainty assigned to a lead con-
centration was derived from propagating
the errors associated with dividing a mea-
sured lead-to-coherent ratio by the slope of
the calibration line and accounting for the
uncertainties in the calibration line. A full
demonstration of the calculation of the
uncertainty on a single measurement is
given in the appendix. Although our serial
phantom measurements were obtained in a
carefully controlled laboratory environ-
ment, we found that the calculated uncer-
tainty on a single measurement underesti-
mates the observed standard error by
approximately 30%. A 30% difference is
significant and meaningful. This suggests
that our formulation ofthe calculated stan-
dard deviation may be incomplete, thereby
underestimating the true standard devia-
tion. Another possible contributor to this
difference, although unlikely, is nonunifor-
mity of lead distributed in our phantom.
This phantom was one ofthe first that was
made to calibrate our system and niay con-
tain pockets ofhigh lead concentration. If
this is true, small errors in repositioning (as
judged by source-to-phantom distance and
phantom rotation) will lead to different
concentration determinations and
increased variance. It has been shown that
the overall lead detection efficiency over a
typical tibia cross-section (4-5 cm) can
vary by more than an order of magnitude
(16).
We have defined in vivo reproducibility
(precision) as the standard deviation from
the mean of a series of measurements and
have suggested typical values of3.4 pg Pb
(g bone mineral)- and 5.1 pg Pb (g bone
mineral)-1 in males and females, respective-
ly. We recently reported a typical measure-
ment error of2.8 pg Pb (g bone mineral)-'
in males (17). This estimate was derived as
the median value from a distribution of30
individual uncertainties in normal males
recorded by our system. This estimated
median value is 18% less than the mea-
sured value we have suggested here. This
does not in itself achieve a high degree of
statistical significance (0.3>p>0.1).
However, taken together with the repro-
ducibility of phantom measurements, it is
reasonable to conclude that serial measure-
ments of bone lead are reliable, but again
there is some increased variance introduced
during in vivo measurements. This increase,
ifit is real, could be accounted for by sub-
ject-dependent parameters such as bone
size, bone mass, subject movement during
measurement, and the thickness ofsoft tissue
overlying the tibia. The effect ofthese sub-
ject-dependent parameters is most appar-
ent by the larger measurement variability
we detected in our two female subjects.
In four out ofthe five subjects we mea-
sured, reproducibility improved on the sec-
ond visit. Although the reproducibility of
bone lead measurements will vary between
subjects, the variability within a subject is
expected to remain constant over a reason-
able length oftime (<1 year) given that no
drastic changes in bone mineral or bone
lead content have occurred. It is quite con-
ceivable that the improved variability we
detected is due to an increase in the opera-
tor's knowledge of the measurement sys-
tem. The effect of operator learning may
be even greater given that the second series
of measurements was recorded with our
detector operating with decreased resolu-
tion and, in some cases, at a reduced
source activity. If the improvement we
have noted is due to operator learning,
small errors in repositioning may be high-
lighting small variations in concentration
within an individual's tibia.
By repeating some ofour in vivo mea-
surements at different source activities, we
were able to assess the effects ofcount rate
on reproducibility. Our findings suggest
that subject- and operator-dependent fac-
tors more strongly influence measurement
reproducibility than source activity. This
can be seen by examining the standard
deviations given in Table 1. All deviations
under visit 1 were recorded with a 1.5-year
old source (0.5 GBq). Consequently, the
variability in the standard deviations are
subject dependent. For visit 2, the first two
subjects were measured with a new source
(1.1 GBq), but their results are no less vari-
able than the remaining three who were
remeasured with an old source (0.3 GBq).
However, a decrease in source activity and
resolution accounts for the increase in the
average calculated uncertainty for all sec-
ond visits.
It was surprising that in one subject a
significant change in lead concentration
was detected. This change is not readily
explained because the expected annual
increase in tibia concentration is very small
[<0.5 pg Pb (g bone mineral) I] (1,2).
Even if the tibia was not measured at the
same position, a significant difference still
should not have been detected at the
p<0.05 level. Atomic absorption measure-
ments of lead concentration have shown
that the concentration of lead sampled
anywhere along the length ofthe tibia will
result in a value within 1 SD of the mean
value of the entire tibial shaft (18). The
apparently significant change may be due
to our detecting the 1 in 20 false positive
difference which is expected at the p<0.05
level.
The confidence intervals given in Table
2 can be used to establish levels ofcertainty
on a detected change in tibia lead concen-
tration. For example, based on a set of
three tibia measurements recorded at the
same site in a typical male, the 95% confi-
dence interval on the difference in concen-
tration between the two measurement sets
will be ± 14.6 pg Pb (g bone mineral)-.
This means that a change in bone lead
concentration of at least 14.6 pg Pb (g
bone mineral)-1 must be measured to be
95% confident that the observed difference
is due to a variation in the subject mea-
sured and not due to measurement uncer-
tainty. As illustrated by Table 2, estimates
of change can be made more precise by
taking additional measurements. This can
be done without being limited by the mag-
nitude ofthe accumulated dose. For exam-
ple, the radiation dose received from five
consecutive tibia lead measurements will
be approximately 0.2 pSv (19). This value
is still far less than the annual dose received
from natural background radiation (2500
pSv).
In deriving the confidence intervals
reported in Table 2, we have assumed that
our measured standard deviation (a) is
only an estimation of the true repro-
ducibility. If one had knowledge of the
true reproducibility and if one assumes
that this true value does not change from
person to person nor over time, then it
would have been more appropriate to
derive confidence intervals based on a nor-
mal z-distribution rather that a t-distribu-
tion. Intervals based on a normal distribu-
tion are smaller than those derived from a
t-distribution. Consequently, the values
given in Table 2 are perhaps an overesti-
mation.
With our small sample size, we found
no evidence for a difference in lead con-
centration between the left and right tibia
within a group of individuals. This con-
firms the findings of other investigators.
For example, no differences in concentra-
tion were noted in the right and left tibia
taken from the archaeological skeletons of
12 colonial American adults as assessed by
atomic absorption spectroscopy (18).
Others have demonstrated strong correla-
tions in the lead content at sites ofsimilar
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bone type such as the trabecular-dominated
sternum and calcaneus (6). Therefore, this
lack ofa detectable difference between two
similar weight-bearing bones with similar
blood supplies means that either tibia
could be sampled in a series of measure-
ments made over time to assess concentra-
tion changes. This may prove useful in
providing an alternative measurement site
in subjects who have broken their legs or
for amputee cases.
In conclusion, it is clear that serial
measurements of bone lead concentration
are reliable enough for a dedicated 109Cd
based K X-ray fluorescence system to be
the instrument of choice in studies
addressing the effects of lead mobilization
from bone. For applications involving lon-
gitudinal studies such as pharmaceutical
interventions, further improvements in
reproducibility will allow shorter study
times and fewer subjects without sacrific-
ingstatistical power.
Appendix
A data set comprised a plaster ofparis phantom, for which there
were a total of 34 measurements, plus an occupationally exposed
male subject and a nonoccupationally exposed female subject. In
each spectrum, estimates, together with la uncertainties, were
obtained for the amplitudes of four lead X-ray peaks (al, a2, 01)
03) and the amplitude ofthe coherent scatter peak (coh). Four cali-
bration lines were determined, in which the ratios (Ri) of X-ray
peak amplitude (xi) to coherent peak amplitude (coh) was
regressed against added lead concentration. For each calibration
line, the slope (mi) and intercept (CQ), together with their vari-
2 2
ehrwtthiva-
ances, Gmi andGi, and their covariance, camiciwere computed.
From a subject spectrum, four estimates oflead concentration
were made:
Pbi 1.46 ,i-C (1)
mi
Ri =Xi (2) coh
and the factor 1.46 is the ratio ofcoherent scattering cross-sections
of bone mineral to hydrated plaster ofparis at 88 keV and 1600.
2 Also the variance,GRi,ofthe ratio is
)2 2 )2
a
2
{- Iaxi~ +[Uycoh
X
iJ
Ri x ) coh
) ,coh (3)
However, this has not taken account ofthe uncertainties in the cal-
ibration line. A more complete calculation ofthe variance in a lead
estimate derived from a singleX-ray,a2bi, is given by
(3b2 cPbi
2 ('2
+ ari Umi(cohCiJ
F2 +4
2 f2( Xi _ A) N 2 ycmi C miXi
c~~coh ) ~coh)
+ + 2
3i 2M
ml~~~~~~~~~~
(7)
2
Then, treating aPbi as the weighting function, wi, for determin-
ing the inverse variance weighted mean, Equation 6 can be rewrit-
ten as:
0rx 1+2 0.21 XiCI
(3.Pb =1.4621 coh) 'i + coh; ) bW Li m2w~ + 4 2 w i mi Wi mi wi
2 Cmi ch - CiJ
co X]
+ 3 2 + 2 2 miWi miwi] (8)
A crude underestimate ofthe measurement variance, 2bb in a lead
estimate derived from a single X-ray can be obtained ifthe calibration
line uncertainties are ignored; that is:
or
TPb2 =(1.46) i
m. (4)
The inverse variance weighted mean, Pb , ofthe four lead concen-
tration estimates, Pb? can then be calculated:
2 Pb. Pb2
PbL= bi
C2 i Pbi
T2 0Pbw
mi(coh
i)
+ 4{Chpcbi 44
(5)
+
which has a variance of:
Pb2
= Y.
I
UPb
b
(6) The fact that each of the terms KcohJ has a mutual dependence
on coh, the coherent scatter amplitude, can be taken into account
by adding another term to Equation 9, giving an overall estimate of
variance, Eapb, which allows for mutual dependence on coh:
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Pb=a:Pbw +1.46 1. (10) coh #jMiM]UPbi.UPbj
Ofthe three estimates ofvariance, 2ib., 2bw' and E2i, the
first accounts only for an individual's measurement error. The sec-
ond additionally accounts for calibration line uncertainties, while
the third also includes the mutual dependence ofeach ofthe four
lead estimates on the same coherent scatter peak amplitude. To
illustrate numerically the differences between these three estimates
ofvariance, the data set of34 phantom measurements and 2 subject
measurements was used. Table Al shows the slopes, intercepts,
variances, and covariances for the four calibration lines. Table A2
shows the X-ray and coherent peak amplitudes for two subjects.
Table A3 shows the results for the two subjects shown in TableA2,
using the calibration line data ofTable Al. The nonoccupationally
exposed female subject showed a larger effect of the calibration
lines because her results were considerably less than the mean val-
ues for the calibration. Her results also showed an extremely small
effect of mutual dependence on coherent peak amplitude because
the additional term in Equation 10 depends on the product ofX-
ray peak amplitudes, which were all small in her case. Even for the
occupationally exposed male subject, whose lead concentration was
substantial (although not extreme), the effect of mutual depen-
dence on coherent peak amplitude was very minor. This demon-
strates that this effect can normally besafelyignored.
The effect ofuncertainties in the calibration lines is to add 2-3%
to the errors estimated in the crudest.fashion. This should not be
ignored because to do so would produce a systematic underestimate of
the measurement error; however, the size ofthe discrepancy remains
small compared to thevariation in error between individuals.
The error, CObw, which allows for uncertainty in the calibration
line, but not for mutual dependence on coherent peak amplitude, is
that which has normally been cited, both from Birmingham (JO) and
McMaster (1).
Table Al. Calibration line data
X-ray Slope Intercept Variance on Variance on Covariance
peak (m) (C) slope (a2 ) intercept(t2) (a2C)
a1 0.00322 0.0184 1.07 x 10 9 5.06 x 10 -4.64 x 10-8
a2 0.00187 0.0134 8.45 x 10-1 4.00 x 106 -3.67 x 108
Pi 6.71 x 10-4 0.00419 6.34 x 10-11 3.00 x 10 -2.75 x 10-9
P3 3.67 x 10-4 0.00140 8.89x 10-11 4.21 x 10-7 -3.86 x 10-9
TableA2. Subject data
B (male) C (female)
Peak Amplitude Uncertainty Amplitude Uncertainty
Coherent(coh) 2523 15.16 3436 17.69
al (x1 421.5 24.81 31.74 29.96
a2 (X2) 313.9 38.52 85.46 50.07
Pi (X3) 81.29 7.399 9.106 8.102
(33 (X4) 34.61 7.532 6.438 8.442
Table A3. Lead estimates and errors
pg Pb(g bonemineral)-'
B(male) C (female)
Lead concentration(Pbd) 65.7 -2.5
Error ignoring calibration (aPb) 3.352 2.884
(98.09)8 (97.04)
Error including calibration (aPb ) 3.408 2.972
(99.75) (99.998)
Error including 3.417 2.972
dependence on coh (EaI) (100) (100)
percentage ofEca~b in parentheses.
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